Mina Baek

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Assessment of safety: In vitro reverse mutation and in vivo acute oral toxicity tests of three biomass products from amino acid-producing Corynebacterium glutamicum.

Assessment of safety: In vitro reverse mutation and in vivo acute oral toxicity tests of three biomass products from amino acid-producing Corynebacterium glutamicum.

Journal: Toxicology reports
Published: July 21, 2024

Identification of differentially expressed mRNA/lncRNA modules in acutely regorafenib-treated sorafenib-resistant Huh7 hepatocellular carcinoma cells.

Identification of differentially expressed mRNA/lncRNA modules in acutely regorafenib-treated sorafenib-resistant Huh7 hepatocellular carcinoma cells.

Journal: PloS one
Published: December 03, 2023

Simultaneous determination of L-tryptophan impurities in meat products.

Simultaneous determination of L-tryptophan impurities in meat products.

Journal: Amino acids
Published: July 11, 2022

Analysis of differentially expressed long non-coding RNAs in LPS-induced human HMC3 microglial cells.

Analysis of differentially expressed long non-coding RNAs in LPS-induced human HMC3 microglial cells.

Journal: BMC genomics
Published: May 18, 2022

The bromodomain inhibitor JQ1 up-regulates the long non-coding RNA MALAT1 in cultured human hepatic carcinoma cells.

The bromodomain inhibitor JQ1 up-regulates the long non-coding RNA MALAT1 in cultured human hepatic carcinoma cells.

Journal: Scientific reports
Published: February 20, 2022

Comprehensive transcriptome profiling of BET inhibitor-treated HepG2 cells.

Comprehensive transcriptome profiling of BET inhibitor-treated HepG2 cells.

Journal: PloS one
Published: November 24, 2021

Targeting of noncoding RNAs encoded by a novel MYC enhancers inhibits the proliferation of human hepatic carcinoma cells in vitro.

Targeting of noncoding RNAs encoded by a novel MYC enhancers inhibits the proliferation of human hepatic carcinoma cells in vitro.

Journal: Scientific reports
Published: September 28, 2021

BET inhibitor suppresses migration of human hepatocellular carcinoma by inhibiting SMARCA4.

BET inhibitor suppresses migration of human hepatocellular carcinoma by inhibiting SMARCA4.

Journal: Scientific reports
Published: October 23, 2020

The BET inhibitor attenuates the inflammatory response and cell migration in human microglial HMC3 cell line.

The BET inhibitor attenuates the inflammatory response and cell migration in human microglial HMC3 cell line.

Journal: Scientific reports
Published: October 15, 2020
Showing 1-9 of 9

Last Updated: 09/26/2026